You just read:

Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients

News provided by

Novartis Pharmaceuticals Corporation

Dec 03, 2010, 07:09 EST